CD8A and neoplasm: Recently, ﻿many studies have demonstrated that the tumor immune microenvironment (TIME) containing the effector of CD8 + , CD4 + cells, regulatory T cells, and dendritic cells (DCs) could affect the efficacy of immune checkpoint inhibitors(ICIs) [11, 12].